论文部分内容阅读
肝细胞癌(HCC)是世界上最多见的恶性肿瘤之一。不幸的是该肿瘤因肝内转移或伴有肝硬化而切除率相当低。加之外科切除病死率高且常复发,系统化疗和放疗效果又不满意,因此,介入放射学在HCC的治疗中就起重要作用。 本文讨论介入放射学的各种模式,如经导管动脉栓塞(TAE)、经皮酒精注射疗法( PEIT)等的适应症、禁忌症、技术、疗效及并发症。在HCC的治疗中,最适当的治疗程序是因每个病例的癌期和肝损程度的不同而异,放了解各种疗法的优缺点十分重要。
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors in the world. Unfortunately, the tumor has a very low resection rate due to intrahepatic metastasis or cirrhosis. In addition to the high mortality rate and frequent recurrence, the effect of systemic chemotherapy and radiotherapy is not satisfactory. Therefore, interventional radiology plays an important role in the treatment of HCC. This article discusses various models of interventional radiology, such as indications, contraindications, techniques, curative effects, and complications such as transcatheter arterial embolization (TAE) and percutaneous alcohol injection (PEIT). In the treatment of HCC, the most appropriate treatment procedure differs depending on the cancer stage and degree of liver damage in each case, and it is important to understand the advantages and disadvantages of various therapies.